Skip to main content

BioPlus Acquisition Corp.

BIOSDelisted Oct 6, 2023
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001856653

BioPlus Acquisition Corp. was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $135.2M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding BioPlus Acquisition Corp. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of BIOS: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders5665+9
Shares17.6M19.3M+1.71M (+9.7%)
Value$173.6M$192.8M+$19.2M (+11.0%)

New holders (15)

Institutions that held BioPlus Acquisition Corp. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to BIOS in Q2 2022
InstitutionSharesValue% of portfolio
UBS Oconnor LLC514,749$5.17M0.05%
Kim, LLC500,000$5.03M0.24%
Mangrove Partners405,141$4.03M0.31%
HSBC Holdings PLC145,000$1.46M0.00%
Magnetar Financial LLC137,841$1.39M0.02%
Bank of Montreal110,100$1.09M0.00%
JPMorgan Chase & Co103,674$1.04M0.00%
Vivaldi Asset Management, LLC100,000$994.0K0.07%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys50,000$501.0K0.01%
Wealthspring Capital LLC39,450$394.0K0.07%
Schechter Investment Advisors, LLC39,450$394.0K0.04%
Sona Asset Management (US) LLC30,000$298.0K0.29%
Toroso Investments, LLC26,586$267.0K0.01%
Robinson Capital Management, LLC26,586$265.0K0.20%
Cohanzick Management, LLC20,000$201.0K0.06%

Sold out (6)

Institutions that held BioPlus Acquisition Corp. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of BIOS in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Spring Creek Capital LLC500,000$4.94M
Beryl Capital Management LLC249,998$2.47M
Wolverine Asset Management LLC242,892$2.40M
Fifth Lane Capital, LP102,500$1.01M
Citadel Advisors LLC88,240$871.0K
Signaturefd, LLC67$2.00K